Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-14

Clinical Trial Update: Randomized Controlled Trial of Renal Denervation for Resistant Hypertension [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating renal denervation for resistant hypertension. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shanghai WiseGain Medical Devices Co., Ltd. | Conditions: Hypertension | Phase 3 | Status: UNKNOWN